IFNG and COVID-19: COVID-19 has been hypothesized to either induce hyperresponsive NK cells that exacerbate lung-destructive inflammation through the production of IFN-γ; or to hamper effective viral clearance by NK cells, such as through suppressing type I interferon responses and reducing circulating cell numbers (Market et al., 2020).